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Extracellular acidification 
stimulates GPR68 mediated IL-8 
production in human pancreatic  
β cells
Vikash Chandra1, Angeliki Karamitri1, Paul Richards1, Françoise Cormier1, Cyrille Ramond1, 
Ralf Jockers1, Mathieu Armanet2, Olivier Albagli-Curiel1 & Raphael Scharfmann1
Acute or chronic metabolic complications such as diabetic ketoacidosis are often associated with 
extracellular acidification and pancreatic β-cell dysfunction. However, the mechanisms by which 
human β-cells sense and respond to acidic pH remain elusive. In this study, using the recently developed 
human β-cell line EndoC-βH2, we demonstrate that β-cells respond to extracellular acidification 
through GPR68, which is the predominant proton sensing receptor of human β-cells. Using gain- and 
loss-of-function studies, we provide evidence that the β-cell enriched transcription factor RFX6 is a 
major regulator of GPR68. Further, we show that acidic pH stimulates the production and secretion of 
the chemokine IL-8 by β-cells through NF-кB activation. Blocking of GPR68 or NF-кB activity severely 
attenuated acidification induced IL-8 production. Thus, we provide mechanistic insights into GPR68 
mediated β-cell response to acidic microenvironment, which could be a new target to protect β-cell 
against acidosis induced inflammation.
In biological systems, cells actively partake in maintaining homeostasis of their environmental milieu within a 
precise range of physiological parameters. Cellular systems also foster the unique ability to respond and adapt to 
physiological stress, preserving survival and function. Signal transduction across cell membrane, through surface 
receptors is fundamental to detect and respond to changes in the local milieu1. Protons (H+) represent an impor-
tant component of the extracellular milieu2. The extracellular fluids and blood pH are tightly regulated and main-
tained judiciously at ~7.4 but under many patho-physiological circumstances such as inflammation, ischemia and 
tumor formation, acidosis occurs in the localized microenvironment3.
Cells sense extracellular protons concentration by a number of mechanisms4,5. Ion channels such as transient 
receptor potential V1 and acid-sensing ion channels (ASICs) represent one sensing mechanism. Such channels 
are predominantly expressed on sensory neurons and act as proton sensors for pain and nociception signals6,7. A 
sub-family of G protein-coupled receptors (GPCR) represents a second type of proton sensing mechanism. This 
includes four members: GPR4, GPR68 (or Ovarian cancer G protein-couple receptor 1, OGR1), GPR65 (or T-cell 
death-associated gene 8, TDAG8) and GPR132 (or G2A). These receptors sense moderate extracellular pH within 
a narrow range (pH 6.0 to 7.6) and signal via a variety of intracellular pathways. For example, GPR68 is coupled 
to the Gq/11-phospholipase-C/Ca2+ pathway, whereas GPR4 and GPR65 are coupled to the Gs-adenyl-cyclase/
cAMP pathway8,9.
Insulin-producing pancreatic β -cells are highly differentiated cells that play a critical role in maintaining glu-
cose homeostasis. They are factories dedicated to produce and secrete insulin in a tightly regulated fashion10. 
β -cells sense a myriad of circulating factors such as glucose, neurotransmitters and hormones that regulate their 
function under physiological conditions11. They are also sensitive to inflammatory cytokines that are impli-
cated in their destruction in type 1 diabetes (T1D)12,13. A recurring complication of T1D is diabetic ketoacidosis 
(DKA) resulting in ketonemia and metabolic acidosis14 with extracellular acidification of the pancreatic microen-
vironment15,16. However, the mechanism by which human β -cells sense proton concentration and transmit 
their signal remains largely unknown. It is likely that moderate acidosis in the pancreatic microenvironment is 
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primarily sensed through the proton sensing GPCR because i) ASICs ion channels are not reported to be present 
in islets,17,18 ii) TRPV1 channels, even though reported to be expressed in some β cell-lines, sense acidic pH (pH 
4–5)17,19–21. Information is limited on the expression and function of proton sensing GPCRs in pancreatic β -cells. 
Impaired glucose-stimulated insulin secretion has been described in GPR68 knockout mice, however the role of 
proton sensing GPCRs in human β -cells remains to be explored22.
Here, we provide evidence that GPR68 is the predominant proton sensing receptor expressed by human 
β -cells. Its expression is tightly regulated by RFX6, a β -cell enriched transcription factor23. We also show using 
the human β cell line Endo-Cβ H224 that extracellular acidification activates GPR68, inducing the production and 
secretion of the chemokine IL-8 through NF-кB activation. In conclusion, proton sensing via GPR68 is a novel 
mechanism for the induction of inflammatory response in human pancreatic β -cell.
Results
The proton-sensing receptor GPR68, a target of RFX6, is expressed in EndoC-βH2 cells and 
human islets. Our previously published transcriptomic analyses (GEO No: GSE48101) indicated that 
EndoC-β H2 cells express mRNA coding for the proton-sensing receptor GPR6824. We validated these data by Real-
Time-quantitative PCR (RT-qPCR) that indicated that GPR68 mRNA expression was enriched in EndoC-β H2 
cells compared to the duct cell line SKPC (Fig. 1a). Transient transfection of EGFP tagged human GPR68 con-
struct in EndoC-β H2 cells showed its predominant localization on the plasma membrane (Supplementary Fig. 1). 
GPR68 was almost the sole proton sensing GPCR expressed in EndoC-β H2 cells, the other ones (GPR4, GPR65, 
GPR132) being expressed at nearly undetectable levels (Fig. 1a). Similar data were obtained using human islet 
preparations that expressed GPR68, but not GPR65 and GPR132 (Fig. 1b). Of note, GPR4 was detected in human 
islets and not in EndoC-β H2 cells (Fig. 1a), which could be due to its expression by non β -cells present in human 
islet preparations like endothelial cells25,26.
RFX6 is a key transcription factor highly expressed in β -cells and required for their function. Our previ-
ous transcriptomic analyses indicated that siRNA-mediated RFX6 knock-down decreased GPR68 expression 
in EndoC-β H2 cells [FC, − 3.85; p = 7.78.10−5] (GEO No: GSE59049) without effecting the expression of other 
proton sensing receptors23. Further validation by RT-qPCR showed that decreased expression level of RFX6 
mRNA (63.92 ± 10.5%) was consistently accompanied by decrease in the level of GPR68 mRNA (59.73 ± 15%) 
in EndoC-β H2 cells (Fig. 2a). Similar results were obtained in human islets where decreased RFX6 expression 
(79.34 ± 13%) resulted in a 42.15 ± 10% decrease of GPR68 transcripts (Fig. 2b). Additionally, overexpression of 
wtRFX6 but not p.V506G mutant RFX623, increased the expression of GPR68 transcripts (Fig. 2c). GPR68 expres-
sion was also enhanced following transfection of EndoC-β H2 cells with a trans-activation domain VP16 conju-
gated RFX6 (Fig. 2d), while transfection of a trans-repression domain conjugated KRAB-RFX6 in EndoC-β H2 
cells resulted in a decreased expression of GPR68 (Fig. 2e). GPR68 is thus the major proton sensor expressed in 
β -cells, its expression being tightly controlled by RFX6.
GPR68 is involved in proton-induced inositol phosphate (IP) production in Human β-cells. 
GPR68 is a proton-sensing Gq/11 coupled receptor that stimulates IP formation to elicit pH dependent responses8. 
To examine if acidification of the extracellular medium activates Gq/11 pathway in EndoC-β H2 cells, we incu-
bated cells at either physiological pH 7.4 or acidic pH 6.4. Buffered pH media did not alter cell morphology, 
viability (Supplementary Fig. 2a–c) or insulin secretion in EndoC-β H2 cells (Supplementary Fig. 3). Acidic pH 
6.4 induced a significant increase in IP formation (Fig. 3a). This effect was blocked by YM-254890, a selective 
Gq/11 inhibitor27, demonstrating the selective role of Gq/11 pathway in pH dependent responses in EndoC-β H2 
(Fig. 3a). On the other hand, proton did not modulate cAMP production measured at pH 7.4 or 6.4 (Fig. 3b), 
Figure 1. Expression of proton sensing GPCRs in EndoC-βH2, SKPC and human islets. Transcript levels 
of proton sensing GPCRs (GPR68, GPR4, GPR65 and GPR132) determined by RT-qPCR in (a) EndoC-β H2 
cells compared with ductal carcinoma SKPC cell-line; (b) human islet preparation. Data represented as mean 
values ± SEM of at least 3 independent experiments. ***p < 0.001; (one-way ANOVA, followed by a Tukey’s 
multiple comparisons post-test).
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further indicating that Gs-coupled receptors such as GPR4 and GPR132 are not involved in proton sensing in 
EndoC-β H2 cells. We next show that acidic pH-stimulated IP production was GPR68-dependent. Indeed control 
(siNT) treated β -cells sensed normally the extracellular acidic pH (6.4) and responded by increasing IP forma-
tion. In contrast siRNA-mediated GPR68 depletion significantly decreased this induction (Fig. 3c). Accordingly, 
siRFX6 treatment lead to decreased GPR68 expression also inhibited proton induced IP formation (Fig. 3c). Thus, 
GPR68 is involved in proton-induced IP production in EndoC-β H2 cells.
EndoC-βH2 cells express and secrete the pro-inflammatory cytokine IL-8 upon exposure to 
acidic pH. Extracellular acidic microenvironment has been reported to induce the expression of pro- and 
anti-inflammatory cytokines in a variety of cell types3,28. We examined the expression of selected cyto/chemok-
ines by EndoC-β H2 cells exposed to acidic pH. RT-qPCR analysis of cells incubated at pH 7.4 or pH 6.4 for 
24 h showed the induction of IL-8 transcripts in cells exposed to acidic pH (Fig. 4a). At all intermediate pH 
tested between 7.4 and 6.4, IL-8 mRNA expression increased while pH decreased (Fig. 4b). Low pH-induced 
IL-8 mRNA expression was detected as early as 8 h following low pH exposition and increased at later time points 
(24 and 48 h) (Fig. 4c). Following incubation at pH 6.4, IL-8 protein was detected in the conditioned medium of 
EndoC-β H2 cells. PMA, a strong inducer of IL-8 in human EndoC-β H2 cell model, was used as positive inducer 
Figure 2. RFX6 regulates GPR68 expression in human β-cells. EndoC-β H2 cells (a) and adult human 
islets (b) were transfected with control non-target siRNA (siNT) or siRNA targeting RFX6 (siRFX6). GPR68 
expression was analyzed 72 h post transfection by RT-qPCR. Data are expressed as percentage of siNT 
transfected cells. (c–e) wtRFX6 and Mut506RFX6 (one-way ANOVA) (c), transactivation domain VP16- 
conjugated RFX6 (d) and transcriptional repression domain KRAB- conjugated RFX6 (e) were expressed in 
EndoC-β H2 cells using bicistronic constructs with IRES-EGFP. GFP+ve cells were FACS isolated 48 h post-
transfection and GPR68 expression was analyzed by RT-qPCR. Data are mean ± SEM of 3–5 experiments. 
*p < 0.05; **p < 0.01; ***p < 0.001 and ns, not significant.
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(Fig. 4d). pH dependent accumulation of IL-8 in EndoC-β H2 cells was further confirmed by immunostaining 
(Fig. 4e).
To test whether acidification induced IL-8 mRNA expression is mediated through GPR68, EndoC-β H2 cells 
were first incubated at acidic pH in the presence of the selective Gq/11 inhibitor YM-254890. Under these condi-
tions, the induction of IL-8 mRNA upon acidic pH is dramatically dampened (Fig. 5a). Moreover both GPR68 
siRNA and RFX6 siRNA also decreased acidic pH-induced IL-8 mRNA induction (Fig. 5b).
IL-8 induction in β-cells by extracellular acidification is NF-кB -dependent. NF-кB is a central 
mediator of inflammatory response29 and RELA, a major subunit of NF-кB complex, is a mediator of IL-8 tran-
scription30. As EndoC-β H2 cells secrete inflammatory cytokine IL-8 in response to acidification of their medium, 
we investigated whether IL-8 production requires NF-кB activation. We showed nuclear translocation of RELA, 
a subunit of NF-кB complex upon acidic pH treatment in EndoC-β H2 cells (Fig. 6a). EMSA performed using 
cellular extracts from EndoC-β H2 showed that DNA-binding activity of NF-кB increased in a time-dependent 
manner when cells were exposed to acidic pH 6.4 (Fig. 6b). Consistent with these results, cell treatment with 
JSH-23, a potent NF-кB activation inhibitor II, significantly decreased acidic pH induced IL-8 mRNA expression 
(Fig. 6c). Moreover, a siRNA that efficiently targeted RELA (Fig. 6d, left), decreased the acidic pH-mediated IL-8 
mRNA induction (Fig. 6d, right). Thus, in EndoC-β H2 cells low pH induces the up-regulation of IL-8 mRNA 
through the activation of NF-кB complex.
IL-8 secreted by human β-cells in acidic conditions attracts neutrophils. IL-8 is a chemotactic 
pro-inflammatory cytokine that mediates the recruitment and activation of neutrophils during inflammation31. 
We examined if IL-8 secreted by EndoC-β H2 cells exposed to acidic pH induces neutrophil chemotaxis. We per-
formed in-vitro migration assay using CD16-positive human blood neutrophils and EndoC-β H2 cell conditioned 
media as chemo-attractant (Fig. 7a). When compared to pH7.4 condition medium, acidic conditioned medium 
significantly attracted blood neutrophils. This chemotactic migration was abrogated by anti-IL-8 antibody indi-
cating that neutrophil migration to acidic conditioned medium is dependent on the presence of IL-8 (Fig. 7b).
Discussion
We and others recently showed that in adult human and mouse pancreatic β -cells, the transcription factor RFX6 
controls insulin secretion by modulating calcium homeostasis23,32. In the present study, we demonstrate that 
RFX6 plays a pivotal role in extracellular proton sensing by regulating the expression of the G-protein coupled 
receptor GPR68 in human β -cells. We next demonstrate that extracellular signal acidification activates GPR68 
which induces the production of inflammatory chemokine IL-8 through activation of the NF-кB complex.
Figure 3. Extracellular pH modulates IP production but not cAMP accumulation in EndoC-βH2 cells. 
(a) IP formation was determined in EndoC-β H2 cells incubated at pH 7.4 and 6.4. The Gq/11-selective inhibitor 
compound YM-254890 (100 nM) was also tested. Results are expressed as fold change over the IP values at pH 
7.4. (b) For cAMP formation assay, EndoC-β H2 cells were incubated for 30 min with and without Forskolin 
(25 μ M) at pH 7.4 or 6.4. Results are expressed as cAMP accumulation (nM) per 5,000 cells. (c) EndoC-β H2 
cells were transfected with control siRNA (siNT), siRNA targeting either GPR68 (siGPR68) or RFX6 (siRFX6). 
72 h post transfection, cells were incubated at pH 7.4 or 6.4 for 30 min and analyzed for the IP formation. Results 
are expressed as fold change over the IP values at pH 7.4. Data are mean ± SEM of 3–5 experiments. *p < 0.05; 
**p < 0.01; ***p < 0.001 and ns, not significant (one-way ANOVA, followed by a Tukey’s multiple comparisons 
post-test).
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GPR68 is one of the 4 known proton sensing GPCRs together with GPR4, 65 and 1325,8. Our results indicate 
that GPR68 is the predominant GPCR of this family in the human β cell-line EndoC-β H2 cells. This appears to 
be also the case in primary human β -cells. Indeed, human islet preparations that contain β -cells, but also some 
endocrine and non endocrine pancreatic cells, express GPR68 but no GPR65 and GPR132 (our present data and 
ref. 25). GPR4 expression is also detected in human islet preparations. However, while GPR68 remains expressed 
in islet β -cell enriched fractions, GPR4 expression levels collapse in such fraction25. Such data suggest that GPR68 
is expressed in primary human β -cells, while GPR4 is expressed in non β -cells in islet preparations.
Signaling via GPCR plays major role in response to neurotransmitters, hormones and environmental stim-
ulants33,34. This is also the case in pancreatic β -cells, where signaling mediated by a number of GPCRs regulate 
β -cell expansion and function35–37. However, limited information is available on the regulation of GPCR expres-
sion38,39. Here, using gain- and loss-of-function approaches, we provide strong evidence that RFX6 is a major 
positive regulator of GPR68 expression. RFX6 knockdown down-regulates GPR68 in EndoC-β H2 cells and in 
human islets. Likewise, overexpression of wtRFX6 enhances GPR68 expression. Finally, converting RFX6 into a 
Figure 4. Acidic extracellular pH induces the expression and secretion of IL-8 by EndoC-βH2 cells.  
(a) EndoC-β H2 cells were cultured at pH 7.4 or 6.4 for 24 h and screened by RT-qPCR for the expression of 
selected pro/anti-inflammatory cytokines. (b) IL-8 expression was determined by RT-qPCR in EndoC-β H2 cells 
cultured at different pH for 24 h (one-way ANOVA, post test for linear trend (p = 0.0008)). (c) IL-8 expression 
was determined by RT-qPCR in EndoC-β H2 cells cultured at pH 7.4 or 6.4 for the indicated time points (one-
way ANOVA, post test for linear trend (p = 0.067)). (d) EndoC-β H2 cells were cultured at pH 7.4 or 6.4 for 
24 h/48 h/72 h or with PMA (100 ng/ml for 12 h) (one-way ANOVA). Secreted IL-8 was quantified by ELISA. 
(e) Immunostaining for IL-8 in EndoC-β H2 cells cultured at pH 7.4 or 6.4 for 72 h or with PMA (100 ng/ml) for 
12 h. Scale bar 10 μ m. Data are mean ± SEM of 3–5 experiments. *p < 0.05; **p < 0.01; ***p < 0.001.
www.nature.com/scientificreports/
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constitutive transcriptional activator (VP16-RFX6) or repressor (KRAB-RFX6) leads to chimeric proteins able 
to increase or decrease, respectively, GPR68 expression. This regulation could be mediated by the direct bind-
ing of RFX6 to the X-box motifs on − 1 K proximal promoter of GPR68 as revealed by promoter analysis using 
MatInspector (data not shown).
Previous data indicated that glucose-stimulated insulin secretion is attenuated in GPR68-deficient mice, sug-
gesting that rodent β -cells sense protons via GPR6822. Here, we show that in human β -cells, GPR68 is expressed 
and is functional. Specifically, in human β -cells, extracellular acidification, through proton-sensing GPR68- Gq/11 
receptor stimulates IP production and activates NF-кB, giving rise to the production and secretion of the inflam-
matory chemokine IL-8. This last point couldn’t have been observed in rodent models, as IL-8 is not expressed by 
rodent cells and considered as a dead gene in murine genome40. Of note, the expression of CXCL1, the functional 
homologs of IL-8 in rodents41, is not induced at low pH in the rodent β -cell line MIN6 (our unpublished data). 
This highlights the need to use human β -cell models such as EndoC-β H2 cells, limits the use of murine models 
and further confirms the major differences between rodent and human β -cells42,43.
In physiological conditions, interstitial pancreatic pH is maintained at ~7.4 while it drops to 7.0 or even below 
in a number of patho-physiological conditions. This is the case in chronic pancreatitis44, or in pancreatic ade-
nocarcinoma45–48. Extracellular pancreatic acidification is also observed in T1D patients with ketoacidosis15,16. 
Whether and how low extracellular pH acts on human β -cells remains poorly studied. Here, we demonstrate 
that in human beta cells, GPR68 senses protons and signals by activating NF-кB complexes, resulting in IL-8 
production and secretion. Interestingly, accumulating evidence indicate elevated levels of IL-8 in pancreas-related 
pathologies such as chronic pancreatitis49, pancreatic adenocarcinoma samples50,51 but also T1D patients with 
severe ketoacidosis episodes52. In this last case, IL-8, by acting as a chemo-attractant, would recruit neutrophils for 
further inflammatory responses and human β -cell destruction. In T1D, β -cells are destroyed by an auto-immune 
reaction and it had been thought that no β -cells can resists this aggression. However, recent data indicate that in 
subgroups of T1D patients, insulin-secreting β -cells that escaped destruction, remain present years after diag-
nostic53,54. A hypothesis would be that such patients had not developed ketoacidosis- induced IL-8 production.
In conclusion, we have identified RFX6 as an important transcriptional regulator of the proton-sensing 
receptor GRP68 in adult human β -cells. We also demonstrated that through GPR68/Gq/11 and NF-кB activation, 
extracellular acidification induces inflammatory chemokine IL-8 production. Earlier reports demonstrated the 
effectiveness of GPR4 antagonist to block inflammatory response to acidosis in endothelial cells55,56. Moreover 
very recent reports have characterized specific modulators of GPR6857. In this context, identifying GPR68 antag-
onists could be novel therapeutic targets for the improvement of inflammatory conditions associated with pan-
creatic acidosis.
Methods
Culture of human cell lines and islets. EndoC-β H2 cells24 were cultured in low-glucose (1g/L) Dulbecco’s 
modified Eagle’s medium (DMEM; Sigma-Aldrich) containing L-glutamine and sodium pyruvate, supplemented 
with 2% BSA fraction V (Roche Diagnostics), 50 μ M 2-mercaptoethanol, 10 mM nicotinamide (Calbiochem), 
5.5 μ g/ml transferrin (Sigma-Aldrich), 6.7 ng/ml selenite (Sigma-Aldrich), 100 U/ml penicillin and 100 μ g/ml 
streptomycin. Cells were seeded on Matrigel (1%)/fibronectin (2 μ g/ml) (Sigma-Aldrich) coated plates and cul-
tured at 37 °C and 5% CO2. The human duct cell line SKPC58 was cultured in high glucose DMEM (4.5 g/L) sup-
plemented with 10% fetal calf serum (Biowest), 100 U/ml penicillin and 100 μ g/ml streptomycin. Human islets 
were isolated and maintained as described59.
Figure 5. IL-8 induction upon extracellular acidification is RFX6- and GPR68-dependent. (a) EndoC-β H2  
cells were cultured for 24 h at pH 7.4 or 6.4 with or without YM-254890 (100 nM), a Gq/11-selective inhibitor 
compound. IL-8 expression was analyzed by RT-qPCR. (b) EndoC-β H2 cells were transfected with siRNA 
(siNT), siGPR68 or siRFX6. After 48 h, cells were cultured for an additional 24 h period at pH 7.4 or 6.4 and 
next analyzed for the expression of IL-8 by RT-qPCR. Data are mean ± SEM of 3–5 experiments. **p < 0.01; 
***p < 0.001 (one-way ANOVA, followed by a Tukey’s multiple comparisons post-test).
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Preparation of buffered culture media. Culture media at different pH were prepared as 
described8,60. Briefly, low glucose DMEM without sodium bicarbonate (Sigma, D2902) was buff-
ered with HEPES (4-(2-Hydroxyethyl) piperazine-1-ethanesulfonic acid; Sigma, H0887), EPPS 
Figure 6. IL-8 induction in EndoC-βH2 cells by extracellular acidification is NF-кB dependent.  
(a) EndoC-β H2 cells were cultured at pH 7.4 or 6.4 for 12 h or with PMA (100 ng/ml for 8 h) and analyzed by 
immunofluoresence for the nuclear accumulation of RELA (p65) component of NF-кB complex. Scale bar  
10 μ m. (b) EndoC-β H2 cells were cultured at pH 7.4 for 8 h, at pH 6.4 for 1, 2 and 8 h or with PMA (100 ng/ml  
for 8 h). Proteins were extracted and used for Electrophoretic mobility shift assay (EMSA) analysis using a 
[32P] radiolabeled NF-кB probe. (c) EndoC-β H2 cells were treated with 1 μ M NF-кB Activation inhibitor-II, 
JSH-23 for 24 h and analyzed for IL-8 expression by RT-qPCR (one-way ANOVA). (d) EndoC-β H2 cells were 
transfected with either control siRNA (siNT) or siRNA targeted RELA (siRELA). After 48 h, siNT or siRELA 
transfected cells were cultured for 24 h at pH 7.4 or 6.4. Efficient RELA knock-down was verified by RT-qPCR 
and immunoblot analysis (left panel). The effect of pH on IL-8 expression following RELA was quantified by RT-
qPCR (right panel) (one-way ANOVA). Data are mean ± SEM of 3–5 experiments. **p < 0.01 and ***p < 0.001.
www.nature.com/scientificreports/
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(4-(2-Hydroxyethyl)-1-piperazinepropanesulfonic acid; Sigma, E9502) and MES (2-(N-Morpholino) ethanesul-
fonic acid; Sigma, M3671) (8mM each) and pH was adjusted with HCl/NaOH. They were kept iso-osmotic by 
adding NaCl and NaHCO3. The pH stability was monitored at the initiation and completion of the experiments.
RNA isolation, reverse transcription and RT-qPCR. Total RNA was extracted from EndoC-β H2 cells 
using RNeasy Plus Micro kit (Qiagen). First strand cDNA was prepared using Maxima First Strand cDNA synthe-
sis kit (ThermoFisher). RT-qPCR was performed using Power SYBR Green mix (Applied Biosystems) with ABI 
Prism 7300 sequence detector (Applied Biosystems). Cyclophilin A transcript levels were used for normalization 
of each target gene. The custom primers were designed with IDT Primer-Quest online software and the ampli-
fication efficiency for each primer was determined with serial dilution of total cDNA from EndoC-β H2/human 
islets cDNA. Primer sequences are listed in Supplementary Table.
siRNA Transfection. EndoC-β H2 cells were transfected using Lipofectamin RNAiMAX (life technologies) 
and ON-TARGETplus siRNA SMARTpool for human RFX6/GPR68/RELA gene (40 nM) or ON-TARGETplus 
Non-targeting pool (siNT) (Dharmacon, Thermo Scientific) as described23. Human islet samples were partially 
dissociated with Accutase (PAA Laboratories) and siRNA transfections were performed as described23.
DNA Transfection. Human RFX6 constructs (pRIG-RFX6, pRIG-Mut506RFX6, pRIG-KRAB-RFX6 and 
pRIG-VP16-RFX6)23 were used in this study. The MGC Human GPR68 cDNAclone (Clone ID: 6971805) was 
purchased (Open Biosystems; Thermo Scientific) and sub-cloned into pEGFP-N1 (Clonetech). EndoC-β H2 cells 
were transiently transfected with DNA using Lipofectamin2000 (Invitrogen) following manufacturer’s instruc-
tions in Opti-MEM. GFP-positive cells were FACS sorted 24–48 h post transfections and RNA expression was 
analyzed by RT-qPCR.
Electrophoretic mobility shift assay for NF-kB. EndoC-β H2 cells were cultured at pH 7.4 (8 h) or 6.4 
(1, 2 and 8 h) or with PMA (100 ng/ml at pH 7.4 for 8 h). Cellular extracts were prepared and NF-кB activation 
was analyzed by electrophoretic mobility shift assay (EMSA) using the human immunodeficiency virus long ter-
minal repeat tandem кB oligonucleotide as кB probe61.
IP and cAMP formation assay. IP formation was quantified with HTRF (Homogeneous Time-Resolved 
Fluorescence) based “Cisbio IP-One Tb” (Cisbio, Bagnols-sur-Cèze, France) assay kit, following manufactur-
er’s instructions. EndoC-β H2 cell suspensions (5 × 104 cells) were treated in 384-well plate (16 μ l volume) with 
modified stimulation buffer (10 mM Hepes, 10 mM MES, 1 mM CaCl2, 0.5 mM MgCl2, 4.2 mM KCl, 146 mM 
NaCl, 5.5 mM glucose, 50 mM LiCl) at pH 7.4 or 6.4 for 60 min at 37 °C. Where indicated, cells were pretreated 
with YM-254890, a selective Gα q/11 inhibitor27 for 30 min prior to incubation with the IP stimulation buffer and 
maintained throughout the IP determination. IP measurements were performed in triplicates and experiments 
were repeated at least three times. Samples were read on a TECAN Infinite F500 (Tecan Group, Ltd., Männedorf, 
Switzerland) with excitation at 320 nm and emission at both 620 nm and 665 nm.
Figure 7. IL-8 secreted by EndoC-βH2 cells in acidic conditions attracts neutrophils. (a) Neutrophils were 
isolated from whole blood using MACSxpress kit, analyzed for the expression of CD16 and used for in-vitro 
transwell migration assay. (b) Neutrophil chemotaxis was tested using conditioned media from EndoC-β H2 
cells cultured at pH 7.4 or pH 6.4 for 72 h. Acidic pH 6.4 conditioned medium pre-treated for 10 min with Anti-
human IL-8 (1 μ g/ml) was also used as well as pH 7.4 conditioned medium supplemented with recombinant 
human-IL-8 (50 ng/ml). Data are represented as migration index, calculated by assigning a value of 1 to the 
number of migrating neutrophils towards pH 7.4-conditioned medium. Data are mean ± SEM of 4 blood 
donors. *p < 0.05; **p < 0.01 (one-way ANOVA, followed by a Tukey’s multiple comparisons post-test).
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cAMP activity was measured using a cAMP-HTRF assay kit (Cisbio) following manufacturer’s instructions. 
EndoC-β H2 cells (5 × 103) were treated in 384-well plate (12 μ l final volume) with stimulation buffer (PBS con-
taining 10 mM of each HEPES, MES, and 0.5 mM IBMX, at pH 7.4 or 6.4) for 30 min at room temperature. Cells 
were lysed using kit lysis buffer and cAMP was then measured in 384 well plates (HTRF) with TECAN Infinite 
F500.
Immunocytochemistry and immunoblotting. EndoC-β H2 cells were cultured on Matrigel/fibronectin 
coated 4-well chambers slide (Nunc Lab-Tek) and processed for IL-8 and RELA immunostaining as described62 
using anti-IL-8 (1:1,000; BD554717; BD Biosciences) or anti-RELA (1:200; sc8008; Santa Cruz Biotechnology) 
antibodies. Images were acquired with a Leica Leitz fluorescent microscope equipped with cooled 3-chip charge 
coupled device camera (Hamamatsu C5810; Hamamatsu) and processed using ImageJ software.
For immunoblot assays, total cellular proteins were prepared as described23. Proteins (25 μ g) were resolved 
by SDS PAGE, immunoblotted with antibodies against RELA (sc8008, 1/250 dilution) and Actin (1/1000, 
Sigma-Aldrich). Membranes were incubated with species-specific HRP-linked secondary antibodies (1:5000) 
and visualization was performed following ECL exposure.
IL-8 Elisa. Secreted IL-8 protein levels were determined using commercially available Human IL-8 ELISA 
MAX Deluxe kit (BioLegend #431504) as per manufacturer’s instructions. EndoC-β H2 cells were treated with 
pH 7.4 or 6.4 or with 100 ng/ml PMA (at pH7.4) and culture supernatants were collected and stored for ELISA.
Neutrophil migration assay. Blood samples were obtained from the pediatric endocrinology and diabetes 
center at Necker Enfants-Malades hospital, Paris, France in accordance with the approved guidelines. All the 
experimental protocols were approved by the local ethic committee (CPP - Paris Ile de France, France). Informed 
consent was obtained from all subjects. Neutrophils were isolated using a MACSxpress human neutrophil iso-
lation kit (Miltenyi Biotec). Red Blood Cell lysis buffer was used to remove residual erythrocytes. The purity of 
isolated neutrophils was consistently between 98–99% based on CD16 staining. Chemotaxis assay was performed 
in 24-well micro chemotaxis chamber using 6.5 mm Transwell with 3 μ m PVP-free polycarbonate filter mem-
brane (Costar). Neutrophils (2 × 105 cells in 200 μ l PBS) in upper chamber were allowed to migrate towards 500 μ l 
of conditioned medium produced during 72 h by EndoC-β H2 cultured at pH 7.4 or 6.4. In some experiments, 
conditioned medium was supplemented with Anti-human IL-8 (1 μ g/ml for 10 min; BD554717; BD Bioscience) 
or with recombinant human-IL-8 (50 ng/ml; BioLegend). After 2 h at 37 °C, migrating cells were recovered with 
Accutase (Sigma) in the lower chamber and numbered by flow cytometry. Results are expressed as migration 
index: number of migrating neutrophils in a defined condition divided by number of migrating neutrophils 
towards pH 7.4 conditioned medium.
Statistics. Graphs were constructed by using PRISM software (version 5.02 GraphPad). Quantitative data 
are presented as the mean ± SEM from at least three independent experiments, unless indicated. For comparison 
between two mean values, statistical significances were estimated using two-tailed Student’s t-test. For compar-
ison between three or more values, one-way ANOVA was used with Tukey’s multiple comparisons post-test. 
Statistical significance was set at p < 0.05.
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